Literature DB >> 15339326

Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls.

J R Boulton-Jones1, R M F Fenn, J West, R F A Logan, S D Ryder.   

Abstract

AIM: Patients with primary biliary cirrhosis may be at increased risk of osteoporosis but to what extent this is reflected in an increased fracture risk is unknown. We have enquired about the fracture experience of female primary biliary cirrhosis patients compared with sex- and age-matched controls.
METHODS: Patients aged 30-75 with primary biliary cirrhosis and age-matched controls were sent a postal questionnaire asking about their fracture history and details of risk factors for osteoporosis.
RESULTS: 85 eligible patients with primary biliary cirrhosis and 116 controls responded. Forty-one per cent of patients with primary biliary cirrhosis and 30% of controls reported ever having had a fracture odds ratio 1.5 (95% confidence interval: 0.80-2.89). Twenty-eight per cent of primary biliary cirrhosis patients and 23.3% of controls reported a fracture after the age of 30, odds ratio 1.2 (95% confidence interval: 0.57-2.56), and 14.1% of primary biliary cirrhosis patients and 12.1% of controls reported a low impact fracture of the long bones or of the vertebrae odds ratio 1.0 (95% confidence interval: 0.31-2.68).
CONCLUSIONS: No overall increased fracture risk in patients with primary biliary cirrhosis was observed. As a group, unselected patients with primary biliary cirrhosis do not represent a population at particularly high risk of osteoporotic fracture and thus targeting them for osteoporosis screening and treatment is not justified. Further work investigating subgroups of patients with primary biliary cirrhosis at potentially high risk of osteoporosis, such as those with advanced disease or severe cholestasis is required. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15339326     DOI: 10.1111/j.1365-2036.2004.02089.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  Association between primary biliary cholangitis and osteoporosis: meta-analysis.

Authors:  Junyu Fan; Qian Wang; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2017-09-26       Impact factor: 2.980

2.  Effects of cirrhosis on bone mineral density and bone metabolism.

Authors:  Mehmet Turkeli; Hakan Dursun; Fatih Albayrak; Nihat Okçu; M Hamidullah Uyanik; Abdullah Uyanik; Rahşan Yıldırım; Mustafa Keleş; Omer Yılmaz
Journal:  Eurasian J Med       Date:  2008-04

3.  Increased risk of osteoporosis in patients with primary biliary cirrhosis.

Authors:  Chen-Yi Liao; Chi-Hsiang Chung; Pauling Chu; Kuang-Yu Wei; Tseng-Min Feng; Fu-Huang Lin; Chang-Huei Tsao; Chia-Chao Wu; Wu-Chien Chien
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

4.  Hepatic encephalopathy increases the risk of hip fracture: a nationwide cohort study.

Authors:  Kuang-Ting Yeh; Tzai-Chiu Yu; Ru-Ping Lee; Jen-Hung Wang; Kuan-Lin Liu; Cheng-Huan Peng; Hao-Wen Chen; Ing-Ho Chen; Chung-Yi Hsu; Wen-Tien Wu
Journal:  BMC Musculoskelet Disord       Date:  2020-11-26       Impact factor: 2.362

5.  Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies.

Authors:  Ta-Liang Chen; Chao-Shun Lin; Chun-Chuan Shih; Yu-Feng Huang; Chun-Chieh Yeh; Chih-Hsing Wu; Yih-Giun Cherng; Chien-Chang Liao
Journal:  BMJ Open       Date:  2017-10-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.